Predict your next investment

Minerva Biotechnologies company logo
HEALTHCARE | Biotechnology
minervabio.com

See what CB Insights has to offer

Total Raised

$43.57M

Investors Count

1

Minerva Biotechnologies Funding, Minerva Biotechnologies Valuation & Minerva Biotechnologies Revenue

7 Fundings

Minerva Biotechnologies's latest funding round was a Loan for $0.25M on April 15, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/15/2020

Loan

$0.25M

$0.00B

((9.99x))

FY 1234

10/30/2019

Unattributed - VI

$99M

$0.00B

((9.99x))

FY 1234

10

4/5/2019

Unattributed - V

$99M

$0.00B

((9.99x))

FY 1234

10

10/24/2014

Unattributed - IV

$99M

$0.00B

((9.99x))

FY 1234

10

10/10/2014

Unattributed - III

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/15/2020

10/30/2019

4/5/2019

10/24/2014

10/10/2014

Round

Loan

Unattributed - VI

Unattributed - V

Unattributed - IV

Unattributed - III

Amount

$0.25M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

10

10

10

10

Minerva Biotechnologies Investors

1 Investors

Minerva Biotechnologies has 1 investors. Paycheck Protection Program invested in Minerva Biotechnologies's Loan funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/15/2020

4/15/2020

1
Loan

Government

DC

First funding

4/15/2020

Last Funding

4/15/2020

Investor

Rounds

1
Loan

Board Seats

Type

Government

Location

DC

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.